Skip to main content
SpringerLink
Log in

Stem Cell Therapy for the Treatment of Hip Osteonecrosis

  • Chapter
  • First Online:
Advances in Specialist Hip Surgery

  • 461 Accesses

Abstract

Avascular necrosis of the femoral head is associated with a risk of hip arthroplasty in younger populations when collapse occurs. This chapter describes surgical procedures using percutaneous stem cells and results for patients with pre-collapse osteonecrosis. Stem cells can be obtained by means of bone marrow aspiration usually with concentration or expansion. Allogenic stem cells can also be used in some situations. Following decompression of the femoral head, these adult mesenchymal stem cells are injected into the osteonecrotic area.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77(3):459–74.

    Article  CAS  PubMed  Google Scholar 

  2. Hernigou P, Beaujean F. Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse. J Bone Joint Surg Am. 1997;79(7):1047–53.

    Article  CAS  PubMed  Google Scholar 

  3. Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br. 1999;81(2):349–55.

    Article  CAS  PubMed  Google Scholar 

  4. Yoon BH, Jones LC, Chen CH, Cheng EY, Cui Q, Drescher W, Fukushima W, Gangji V, Goodman SB, Ha YC, Hernigou P, Hungerford M, Iorio R, Jo WL, Khanduja V, Kim H, Kim SY, Kim TY, Lee HY, Lee MS, Lee YK, Lee YJ, Mont MA, Sakai T, Sugano N, Takao M, Yamamoto T, Koo KH. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 2: alcohol-associated osteonecrosis. J Arthroplast. 2019;34(1):169–174.e161. https://doi.org/10.1016/j.arth.2018.09.006.

    Article  Google Scholar 

  5. Salem KH, Brockert AK, Mertens R, Drescher W. Avascular necrosis after chemotherapy for haematological malignancy in childhood. Bone Joint J. 2013;95-B(12):1708–13. https://doi.org/10.1302/0301-620X.95B12.30688.

    Article  CAS  PubMed  Google Scholar 

  6. Yamamoto T, Hirano K, Tsutsui H, Sugioka Y, Sueishi K. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop Relat Res. 1995;(316):235–43.

    Google Scholar 

  7. Merschin D, Hane R, Tohidnezhad M, Pufe T, Drescher W. Bone-preserving total hip arthroplasty in avascular necrosis of the hip—a matched-pairs analysis. Int Orthop. 2018;42(7):1509–16. https://doi.org/10.1007/s00264-018-3896-9.

    Article  PubMed  Google Scholar 

  8. Hernigou P, Trousselier M, Roubineau F, Bouthors C, Chevallier N, Rouard H, Flouzat-Lachaniette CH. Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress. Clin Orthop Surg. 2016;8(1):1–8. https://doi.org/10.4055/cios.2016.8.1.1.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hernigou P. Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka. Int Orthop. 2015;39(4):807–17. https://doi.org/10.1007/s00264-015-2716-8.

    Article  PubMed  Google Scholar 

  10. Hernigou P, Daltro G, Hernigou J. Hip osteonecrosis: stem cells for life or behead and arthroplasty? Int Orthop. 2018;42(7):1425–8. https://doi.org/10.1007/s00264-018-4026-4.

    Article  PubMed  Google Scholar 

  11. Hernigou J, Alves A, Homma Y, Guissou I, Hernigou P. Anatomy of the ilium for bone marrow aspiration: map of sectors and implication for safe trocar placement. Int Orthop. 2014;38(12):2585–90. https://doi.org/10.1007/s00264-014-2353-7.

    Article  PubMed  Google Scholar 

  12. Hernigou J, Picard L, Alves A, Silvera J, Homma Y, Hernigou P. Understanding bone safety zones during bone marrow aspiration from the iliac crest: the sector rule. Int Orthop. 2014;38(11):2377–84. https://doi.org/10.1007/s00264-014-2343-9.

    Article  PubMed  Google Scholar 

  13. Hernigou P, Homma Y, Flouzat Lachaniette CH, Poignard A, Allain J, Chevallier N, Rouard H. Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells. Int Orthop. 2013;37(11):2279–87. https://doi.org/10.1007/s00264-013-2017-z.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hernigou P, Thiebaut B, Housset V, Bastard C, Homma Y, Chaib Y, Flouzat Lachaniette CH. Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side. Int Orthop. 2018;42(7):1593–8. https://doi.org/10.1007/s00264-018-3953-4.

    Article  PubMed  Google Scholar 

  15. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;(405):14–23.

    Google Scholar 

  16. Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am. 2004;86-A(6):1153–60.

    Article  Google Scholar 

  17. Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005–9. https://doi.org/10.1016/j.bone.2011.07.032.

    Article  PubMed  Google Scholar 

  18. Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplast. 2012;27(5):679–86. https://doi.org/10.1016/j.arth.2011.08.008.

    Article  Google Scholar 

  19. Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, Liu B, Yu X. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50(1):325–30. https://doi.org/10.1016/j.bone.2011.11.002.

    Article  PubMed  Google Scholar 

  20. Piuzzi NS, Chahla J, Jiandong H, Chughtai M, LaPrade RF, Mont MA, Muschler GF, Pascual-Garrido C. Analysis of cell therapies used in clinical trials for the treatment of osteonecrosis of the femoral head: a systematic review of the literature. J Arthroplast. 2017;32(8):2612–8. https://doi.org/10.1016/j.arth.2017.02.075.

    Article  Google Scholar 

  21. Hernigou P, Dubory A, Homma Y, Guissou I, Flouzat Lachaniette CH, Chevallier N, Rouard H. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018;42(7):1639–49. https://doi.org/10.1007/s00264-018-3941-8.

    Article  PubMed  Google Scholar 

  22. Hernigou P, Guerin G, Homma Y, Dubory A, Chevallier N, Rouard H, Flouzat Lachaniette CH. History of concentrated or expanded mesenchymal stem cells for hip osteonecrosis: is there a target number for osteonecrosis repair? Int Orthop. 2018;42(7):1739–45. https://doi.org/10.1007/s00264-018-4000-1.

    Article  PubMed  Google Scholar 

  23. Gomez-Barrena E, Rosset P, Gebhard F, Hernigou P, Baldini N, Rouard H, Sensebe L, Gonzalo-Daganzo RM, Giordano R, Padilla-Eguiluz N, Garcia-Rey E, Cordero-Ampuero J, Rubio-Suarez JC, Stanovici J, Ehrnthaller C, Huber-Lang M, Flouzat-Lachaniette CH, Chevallier N, Donati DM, Ciapetti G, Fleury S, Fernandez MN, Cabrera JR, Avendano-Sola C, Montemurro T, Panaitescu C, Veronesi E, Rojewski MT, Lotfi R, Dominici M, Schrezenmeier H, Layrolle P. Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial. Biomaterials. 2018;196:100. https://doi.org/10.1016/j.biomaterials.2018.03.033.

    Article  CAS  PubMed  Google Scholar 

  24. Hernigou P, Bernaudin F, Reinert P, Kuentz M, Vernant JP. Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. J Bone Joint Surg Am. 1997;79(11):1726–30.

    Article  CAS  PubMed  Google Scholar 

  25. Woodell-May JE, Tan ML, King WJ, Swift MJ, Welch ZR, Murphy MP, McKale JM. Characterization of the cellular output of a point-of-care device and the implications for addressing critical limb ischemia. Biores Open Access. 2015;4(1):417–24. https://doi.org/10.1089/biores.2015.0006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hernigou P, Homma Y, Flouzat-Lachaniette CH, Poignard A, Chevallier N, Rouard H. Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate. J Bone Joint Surg Am. 2013;95(24):2215–21. https://doi.org/10.2106/JBJS.M.00261.

    Article  PubMed  Google Scholar 

  27. Hernigou P, Flouzat Lachaniette CH, Delambre J, Chevallier N, Rouard H. Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence? Int Orthop. 2014;38(9):1825–35. https://doi.org/10.1007/s00264-014-2384-0.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hôpital Henri Mondor, University Paris East (UPEC), Creteil, France

    Philippe Hernigou

  2. Department of Orthopedics, RWTH Aachen University Hospital, Aachen, Germany

    Wolf R. Drescher

  3. Orthopedic Surgery of the Lower Limb and Arthroplasty, Rummelsberg Hospital, Schwarzenbruck, Germany

    Wolf R. Drescher

Authors
  1. Philippe Hernigou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolf R. Drescher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Orthopedics, RWTH Aachen University Hospital, Aachen, Germany

    Wolf R. Drescher

  2. Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea (Republic of)

    Kyung-Hoi Koo

  3. Orthopaedic Surgery, Hip and Knee Replacement, Hospital of Special Surgery, New York, NY, USA

    Russell E. Windsor

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hernigou, P., Drescher, W.R. (2021). Stem Cell Therapy for the Treatment of Hip Osteonecrosis. In: Drescher, W.R., Koo, KH., Windsor, R.E. (eds) Advances in Specialist Hip Surgery . Springer, Cham. https://doi.org/10.1007/978-3-030-61830-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-61830-8_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-61829-2

  • Online ISBN: 978-3-030-61830-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation